This was the first evidence that the production of bioactive peptide (Lys-Asp-Leu-Glu-Leu) effectively suppresses the lipogenic protein (SREBP, FAS, and ACC) and gene expressions, and down-regulates obesity and diabetes. The gene discussed is FAS; the disease is obesity disorder.